Skip to main content
$0.41 -$0.01 (-1.3%)

04:00 PM EST on 12/07/23

Precision Biosciences (NASDAQ:DTIL)

CAPS Rating: 2 out of 5

Current Price $0.41 Mkt Cap $49.0M
Open $0.41 P/E Ratio -0.56
Prev. Close $0.41 Div. (Yield) $0.00 (0.0%)
Daily Range $0.37 - $0.42 Volume 604,647
52-Wk Range $0.28 - $1.45 Avg. Daily Vol. 875,684

Caps

This ticker is not currently Ratable.

Add Stock to CAPS Watchlist

All Players

20 Outperform
4 Underperform
 

All-Star Players

3 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:DTIL Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

offerbk1 (< 20)
Submitted February 21, 2021

Gene Editing is at its start. DTIL has patents and a system that is more efficient than CRSP/NTLA/EDIT which is based on tech that won Nobel Prize. Moreover the MktCap of these 3 shows us that DTIL is undervalued due to the fact it is less known and… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

NASDAQ:DTIL Summary

Fools bullish on NASDAQ:DTIL are also bullish on:

Fools bearish on NASDAQ:DTIL are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about DTIL.

Recs

1
Member Avatar offerbk1 (< 20) Submitted: 2/21/2021 12:58:54 PM : Outperform Start Price: $12.05 NASDAQ:DTIL Score: -115.03

Gene Editing is at its start. DTIL has patents and a system that is more efficient than CRSP/NTLA/EDIT which is based on tech that won Nobel Prize. Moreover the MktCap of these 3 shows us that DTIL is undervalued due to the fact it is less known and promoted. While there is still no product DTIL already has big pharma lining up for partnership and also a business for agriculture. The future seems very bright for DTIL and as the products trials and eventually products will be released I beleive DTIL could be anywhere between 10x and 100x in the next 5 years.

Recs

2
Member Avatar MattK520 (< 20) Submitted: 3/28/2019 11:30:05 AM : Outperform Start Price: $18.00 NASDAQ:DTIL Score: -161.20

Revolutionary gene editing technology, alternative to CRISPR

Leaderboard

Find the members with the highest scoring picks in DTIL.

Score Leader

TheFall2021

TheFall2021 (93.39) Score: +116.13

The Score Leader is the player with the highest score across all their picks in DTIL.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
TheFall2021 93.39 1/21/2021 Underperform 5Y $13.71 -97.05% +19.09% +116.13 0 Comment
GabrielSevrs < 20 6/8/2021 Underperform 3W $11.60 -96.51% +8.45% +104.96 0 Comment
sikiliza < 20 7/28/2021 Underperform 5Y $9.77 -95.85% +4.22% +100.07 0 Comment
wsmoot8796 77.59 6/9/2022 Underperform 1Y $1.76 -76.99% +11.94% +88.93 0 Comment
Playa17 < 20 11/17/2022 Outperform 5Y $1.53 -73.53% +17.36% -90.89 0 Comment
MattMarlatt < 20 4/29/2021 Outperform 5Y $9.57 -95.77% +9.10% -104.87 0 Comment
TruffelPig < 20 5/11/2021 Outperform 5Y $7.85 -94.84% +10.92% -105.77 0 Comment
GrapeFool < 20 2/19/2021 Outperform 5Y $11.46 -96.47% +16.87% -113.34 0 Comment
kefuerst < 20 2/22/2021 Outperform 5Y $12.05 -96.64% +18.39% -115.03 0 Comment
offerbk1 < 20 2/22/2021 Outperform 5Y $12.05 -96.64% +18.39% -115.03 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for DTIL.